Evidence and controversies in the use of post-mastectomy radiation

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 5, Issue 3, 2007, Pages 331-338

  Fernando, Shaneli A ^a   Edge, Stephen B ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Breast cancer; Chemotherapy; Locoregional failure; Lymph node; Mastectomy; NCCN Breast Cancer Clinical Practice Guidelines in Oncology; Post mastectomy radiation

Indexed keywords

ANTIESTROGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; MASTECTOMY; MORBIDITY; PNEUMONIA; POSTOPERATIVE CARE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT FAILURE;

EID: 33947493299     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2007.0028     Document Type: Review

References (39)

1. Carlson RW, Anderson BO, Burstein HJ, et al. NCCN breast cancer clinical practice guidelines in oncology. Version 1, 2007. Available at: http://www.nccn.org/physician_gls/PDF/breast.pdf. Accessed January 25, 2007.
2. Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years afrer mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999;17:1689-1700.
3. Jagsi R, Raad RA, Goldberg S, et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys 2005;62:1035-1039.
4. Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000;18:2817-2827.
5. Katz A, Strom EA, Buchholz TA, et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 2001;50:735-742.
6. Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 2004;22:4247-4254.
7. Wallgren A, Bonetti M, Gelber RD, et al. Risk factors for locoregional recurrence among breast cancer patients: results from international breast cancer study group trials I through VII. J Clin Oncol 2003;21:1205-1213.
8. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet 1999;353:1641-1648.
9. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:936-962.
10. Ragaz J, Olivotto IA, Spinell JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005;97:116-126.
11. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 2000;355:1757-1770.
12. Clarke M, Collins R, Darby C, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005;366:2087-2106.
13. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949-955.
14. Whelan TJ, Julian J, Wright J, et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000;18:1220-1229.
15. Benson EA, Thorogood J. The effect of surgical technique on local recurrence rates following mastectomy. Eur J Surg Onc 1986;12:267-271.
16. Helinto M, Blomqvist C, Heikkila P, Joensuu H. Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed? Radiother Oncol 1999;52:213-217.
17. Taghian AG, Jeong JH, Manmouas EP, et al. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 2006;24:3927-3932.
18. Floyd, SR, Buchholz TA, Haffty BG, et al. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. Int J Radiat Oncol Biol Phys 2006;66:358-364.
19. Freedman GM, Fowble BL, Hanlon AL, et al. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. Int J Radiat Oncol Biol Phys 1998;41:599-605.
20. Strom EA, McNeese MD. Postmastectomy irradiation rationale for treatment field selection. Semin Radiat Oncol 1999;9:247-253.
21. Strom EA, Woodward WA, Katz A, et al. Clinical investigation: regional nodal failure patterns in breast cancer patients treated wirh mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:1508-1513.
22. Pierce LJ, Oberman HA, Strawderman MH, Lichter AS. Microscopic extracapsular extension in the axilla: is this an indication for axillary radiotherapy? Int J Radiat Oncol Biol Phys 1995;33:253-259.
23. Rech A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: guidelines for the American Society of Clinical Oncology. J Clin Oncol 2001;19:1589-1569.
24. Lingos TI, Recht A, Vacini F. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1991;21:355-360.
25. Marks LB. Pulmonary effects of thoracic irradiation. Oncology 1994;8:89-100.
26. Burstein HJ, Bellon JR, Galper S, et al. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for stage II or III breast cancer. Int J Radiat Oncol Biol Phys 2006;64:496-504.
27. Halyard M, Pisansky L, Solin U, et al. Adjuvant radiotherapy (RT) and trasruzumab in stage I-IIA breast cancer; toxicity data from the North Central Cancer Treatment Group Phase III trial N9831. J Clin Oncol 2006;24(suppl 1):8S. Abstract 523.
28. Nixon AJ, Manola J, Gelman R. No long term increase in cardiac-related mortality after breast conserving surgery and radiation using modern techniques. J Clin Oncol 1998;16:1374-1379.
29. Harris EE, Correa C, Hwang WT, et al. Late cardiac mortality and morbidity in early srage breast cancer patients after breast conservation treatment. J Clin Oncol 2006;24:4100-4106.
30. Larson D, Weinstein M, Goldberg I. Edema of the arm as a function of the extent of axillary surgery in patient with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:1575-1582.
31. Hinrichs CS, Watroba NL, Rezaishiraz H, et al. Lymphedema secondary to post-mastectomy radiation: incidence and risk factors. Ann Surg Oncol 2004;11:573-580.
32. Yeoh EK, Denham JW, Davies SA, Spittle MF. Primary breast cancer. Complications of axillary management. Acta Radiol Oncol 1986;25:105-108.
33. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissues to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-122.
34. Taghian A, de Vathaire F, Terrier P, et al. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 1991;21:361-367.
35. Neugut AI, Robinson H, Lee WC, et al. Lung cancer after radiation therapy for breast cancer. Cancer 1993;71:3054-5057.
36. Chawla AK, Kachnic LA, Taghian AG, et al. Radiotherapy and breast reconstruction: complication and cosmesis with TRAM versus tissue expander/ implant. Int J Radiat Oncol Biol Phys 2002;54:520-526.
37. Krueger EA, Wilkinson EG, Strawderman MH, et al. Complications and patient satisfaction following expander/ implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys 2001;49:713-721.
38. Ascherman JA, Hanasono MM, Newman MI, Hughes DB. Implant reconstruction in breast cancer patients treated with radiation therapy. Plast Reconstr Surg 2006;117:359-365.
39. Motwani SB, Strom EA, Schechter NR, et al. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:76-82.